Morgan Mills, MD

Closed
Call
Website

Advertisement

Photos

601 N Caroline St Fl 6
Baltimore, MD 21287
Neurologist Kelly Mills cares for patients who have movement disorders such as ataxia, dystonia, Parkinson’s disease, atypical parkinsonism and tremor. He evaluates and manages patients needing advanced therapies, such as deep brain stimulation, focused ultrasound or medication infusions to manage their movement symptoms. Additionally, he provides botulinum toxin treatment for various disorders. Dr. Mills earned his medical degree from the University of Maryland School of Medicine. He completed residency training in neurology at the University of California, San Francisco School of Medicine and remained there for fellowship training in movement disorders, which had a particular emphasis on deep brain stimulation to treat Parkinson’s disease, tremor and dystonia. Dr. Mills also holds a Master of Health Sciences from the Johns Hopkins Bloomberg School of Public Health. In his research, Dr. Mills explores the cognitive dysfunction that can occur in movement disorders such as Parkinson’s disease. He is particularly interested in describing the role of the basal ganglia in cognition, especially in the context of various diseases that can affect this structure. His work focuses on clarifying how certain treatments might affect cognitive and psychiatric problems. He also works to develop new imaging biomarkers to detect mechanisms of disease, such as neuroinflammation in Parkinson’s disease.
Request an Appointment
Owner verified
See a problem?

You might also like

Alisa Coker, MD
Respiratory health clinic, Internal medicine practitioners, Psychiatrists and psychoanalysts

Alisa Coker, MD

Matthew Ippolito, M.D., Ph.D. is an Associate Professor of Medicine and the Director of Clinical Epidemiology for the Southern and Central Africa International Centers of Excellence for Malaria Research (ICEMR). He received his A.B. from Dartmouth College and his M.D. from the Geisel School of Medicine at Dartmouth. He completed his Internal Medicine Internship and Residency at the University of California, San Francisco, and fellowships in Infectious Diseases and Clinical Pharmacology at the Johns Hopkins University School of Medicine where he received his Ph.D. in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. He also served in the Peace Corps in Ghana, West Africa. Dr. Ippolito specializes in global health and tropical infectious diseases with a research focus on malaria in sub-Saharan Africa. His NIH-supported research program explores the clinical pharmacology of antimalarial drugs and the genetic epidemiology of drug resistance. In his role as Director of Clinical Epidemiology for the Southern and Central Africa ICEMR, Dr. Ippolito designs and oversees clinical, translational, and epidemiological studies of malaria. Dr. Ippolito also serves as a Phase I and II clinical trialist for the LONGEVITY consortium, established to develop and deploy long-acting nanoformulations of essential anti-infective drugs. He is also a co-developer of a computer vision-based machine learning platform for malaria diagnostic and research applications, and serves on the editorial board of Frontiers in Malaria.
United StatesMarylandBaltimoreMorgan Mills, MD

Partial Data by Infogroup (c) 2026. All rights reserved.

Yext

Partial Data by Foursquare.

Advertisement